Delivery Order SPE2DB20D3103-SPE2DB24FP7X8

Award Date 8/6/24
Potential Completion Date 8/7/24
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp., a major pharmaceutical distributor and healthcare solutions provider. The $3,808.92 firm fixed-price delivery order is for the supply of Epogen (epoetin alfa) 4,000 units/mL vials. The contract has an ultimate completion date of March 29, 2023 and does not include any set-aside requirements, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,046.41 firm fixed-price delivery order is for the procurement of EPOGEN 10,000 units/mL vials, with a period of performance running through May 23, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $3,976.20 firm fixed price delivery order is for the supply of EPOGEN 20,000 units/mL vials, a specialty pharmaceutical product. The contract does not utilize any set-aside designations and has a completion date of February 26, 2024. AmerisourceBergen Drug Corp,...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $2,681.01 contract is for the delivery of Epogen 4,000 units/mL vials to support military treatment programs and facilities. This delivery order falls under a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of...
This is a federal contract award issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $5,350.68 firm fixed-price delivery order is for the supply of Epogen, a 20,000 unit/2 mL injectable medication used to treat anemia. The contract has an ultimate completion date of October 16, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This federal contract award, with ID SPE2DB20D3103|SPE2DB23FP0R5, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,711.97 delivery order is for EPOGEN 2,000 units/mL vials and has a firm fixed price. The contract has a completion date of July 21, 2023 and was awarded on July 20, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and is a critical supplier of pharmaceutical products and medical supplies...
This federal contract award, valued at $1,099.26, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EPOGEN 3,000 units/mL vials, a specialty medication used for the treatment of anemia. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of May 9, 2023. It is not designated as a set-aside contract....
This federal contract award is for the delivery of pharmaceutical products, specifically EPOGEN 10MU/ML 1ML 6S, to support U.S. government agencies. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a Delivery Order with a Firm Fixed Price type, valued at $3,495.28, and has an ultimate completion date of November 28, 2023. It was awarded by the Defense Logistics Agency (DLA) Troop Support...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of EPOGEN 4,000 units/ml pharmaceutical vials. The $1,118.55 contract has a completion date of March 5, 2024. This order is issued under an existing indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, which serves as the primary vehicle for the company to deliver a range of...
Defense Logistics Agency awarded a $1,129.31 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4,000 units/ml vials of Epoetin Alfa, also known as Epogen. The delivery order was awarded on October 17, 2023 under the prime contractor's corporate office division in Conshohocken, Pennsylvania, with performance required by October 18, 2023. No set-aside designation was applied to this procurement. Epogen is a medication commonly used to treat anemia, a condition addressed...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FP7X8
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $2,288.60 firm-fixed-price delivery order is for the supply of Epogen 10,000 units/mL vials. The contract has an ultimate completion date of August 7, 2024.

Amerisourcebergen Drug Corp is a major pharmaceutical distributor that provides a wide range of medical products to federal government agencies, including the military. The company holds two significant Indefinite Delivery Contracts (IDCs) - one with the DLA valued at $999,999,999 and another with the Department of Justice Federal Bureau of Investigation valued at $750,000. These IDCs enable efficient procurement of critical pharmaceutical and medical supplies to support the healthcare needs of military personnel, veterans, and other federal beneficiaries.

This particular award was not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp, as the prime contractor, is responsible for delivering the Epogen vials to the specified location in Conshohocken, Pennsylvania.

Generated 2/27/25, 11:13 AM